Dr. Wooldridge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Checkmate Pharmaceuticals
Cambridge, MA 02142
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1996 - 1999- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1992 - 1996
Tulane University School of MedicineClass of 1992
Certifications & Licensure
MO State Medical License 1999 - 2026
Publications & Presentations
PubMed
- 3 citationsNeoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin
Cancer Cell. 2024-11-11 - 2 citationsVidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-...Marcelo V Negrao, Vassiliki A Papadimitrakopoulou, Andrew C Price, Alda L Tam, Muhammad Furqan
JTO Clinical and Research Reports. 2023-03-01 - 72 citationsOvercoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.Antoni Ribas, Theresa Medina, John M. Kirkwood, Yousef Zakharia, Rene Gonzalez
Cancer Discovery. 2021-07-29
Press Mentions
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009January 4th, 2023
Checkmate Pharmaceuticals Announces Additions to Management TeamOctober 15th, 2019
Grant Support
- CPG 7909 In Previously Treated Chronic Lymphocytic LeukemiaNational Center For Research Resources2005–2006
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
